ArticleFolia microbiologica2026
Purification and characterization of β-galactosidase from Aspergillus niger PQ570689 for lactose hydrolysis and prebiotic synthesis.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CRISPR-Cas9 Gene Editing inBiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
β-Galactosidase converts lactose to galactose and glucose, and it is significant for lactose-intolerant people. A Nigerian local strain of Aspergillus niger (accession number PQ570689) previously isolated from fermented goat milk in Minna, Niger State, Nigeria, was used to produce β-galactosidase. Diammonium sulfate precipitation and gel filtration were used to purify the crude enzyme. The impacts of temperature (10, 20, 30, 40, and 50 °C), pH (4, 5, 6, 7, and 8), metal ions (Fe, Mn, Cu, and Mg), chemical activators/inhibitors (SDS and Tween-80), sugars (fructose, glucose, and sucrose), and substrate concentrations (o-nitrofenyl-beta-D-galaktopyranoside (ONPG)) on the purified enzyme activity were determined. The kinetic parameters including Vmax (maximum velocity) and Km (Michaelis-Menten constant) of the partially purified enzyme were also estimated. Afterwards, lactose hydrolysis and prebiotic production potential of the purified beta-galactosidase was evaluated using high-performance liquid chromatography (HPLC). The purified enzyme was characterized by the highest enzyme activity (338 U/mL), specific activity (18.82 U/mL per mg), and fold purification (35.78), as well as the least protein content (18 mg/mL). The purified β-galactosidase was most active at pH 7 and 50 °C. The enzyme was, however, inhibited by all the metal ions, surfactants, and sugars tested. This biocatalyst was characterized by a substantial catalytic capability (Vmax = 666.67 U/mL per min) and moderate affinity (Km = 8.67 mmol) to its substrate. The purified enzyme showed a great potential for lactose hydrolysis (> 99%) as well as a good prospect for prebiotics synthesis (7%). Thus, the β-galactosidase can be developed for various industrial, environmental, and biotechnological applications.
Indexed as
Identifiers
40615754What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.